| Jasmine Stompanato, PHARMD | |
|
1193 Admiral Callaghan Ln, Vallejo, CA 94591-3701 | |
| (707) 552-0496 | |
| Not Available |
| Full Name | Jasmine Stompanato |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1193 Admiral Callaghan Ln, Vallejo, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043933153 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 86869 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jasmine Stompanato, PHARMD 1193 Admiral Callaghan Ln, Vallejo, CA 94591-3701 Ph: () - | Jasmine Stompanato, PHARMD 1193 Admiral Callaghan Ln, Vallejo, CA 94591-3701 Ph: (707) 552-0496 |
News Archive
The U.S. Food and Drug Administration have announced that a heart-failure drug manufactured for African-Americans significantly reduced deaths and hospitalizations and its side effects were similar to those of a placebo's.
FDA review periods are lengthening for IVD tests that utilize molecular biomarkers, and at a faster rate than for IVDs overall, one of the key findings in a new report published this month by Amplion Research.
Research led by St. Jude Children's Research Hospital scientists has identified a potential target in the quest to develop a more effective treatment for leishmaniasis, a parasitic tropical disease that kills thousands and sickens more than 1 million people worldwide each year.
Today's headlines focus on the the timing, politics, costs and contents of pending health overhaul bills, as well as a soon-to-be released GOP alternative.
XenoPort, Inc. announced today its financial results for the fourth quarter and year ended December 31, 2013. Revenues for the fourth quarter were $2.9 million, compared to $0.5 million for the same period in 2012. Net loss for the fourth quarter was $19.1 million compared to net income of $3.0 million that resulted from a non-cash gain from XenoPort's litigation settlement with Glaxo Group Limited in the fourth quarter of 2012. At December 31, 2013, XenoPort had cash and cash equivalents and short-term investments of $58.7 million.
› Verified 5 days ago
Rihong Zhou, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 975 Sereno Dr, Vallejo, CA 94589 Phone: 707-651-2072 | |
Christina Crowley, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1193 Admiral Callaghan Ln, Vallejo, CA 94591 Phone: 707-552-0496 | |
Dr. Lindsey Rich, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 975 Sereno Dr, Inpatient Pharmacy, Vallejo, CA 94589 Phone: 707-651-2072 | |
Ms. Grace H Le, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 975 Sereno Dr, Medicine 8, Vallejo, CA 94589 Phone: 707-651-4265 Fax: 707-651-2821 | |
Michelle Gandley, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 122 Robles Way, Vallejo, CA 94591 Phone: 707-554-6908 Fax: 707-554-2347 | |
Lily Phuong, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 975 Sereno Dr, Vallejo, CA 94589 Phone: 707-651-5403 | |
Hieu Minh Phan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Hospital Dr, Vallejo, CA 94589 Phone: 707-554-5050 Fax: 707-554-5111 |